Evidence map›Paper›PMID 38129393›Full record

ArticleBlood cancer journal2023

Myeloid neoplasm occurrence during stable molecular remission of NPM1-mutated AML: are we facing secondary disease or AML relapse?

Carlotta Giupponi, Diego Bertoli, Erika Borlenghi, Chiara Cattaneo, Tatiana Zollner, Lorenzo Masina, Samuele Bagnasco, Elisa Cerqui, Francesca Federico, Chiara Pagani and 4 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood cancer journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Carlotta Giupponi *Hematology, ASST Spedali Civili, Brescia, Italy. giupponicarlotta@gmail.com.ORCID 0009-0003-4897-3741
Diego Bertoli *Clinical Chemistry Laboratory, ASST Spedali Civili, Brescia, Italy.
Erika BorlenghiHematology, ASST Spedali Civili, Brescia, Italy.
Chiara CattaneoHematology, ASST Spedali Civili, Brescia, Italy.ORCID 0000-0003-0031-3237
Tatiana ZollnerHematology, ASST Spedali Civili, Brescia, Italy.
Lorenzo MasinaHematology, ASST Spedali Civili, Brescia, Italy.
Samuele BagnascoHematology, ASST Spedali Civili, Brescia, Italy.
Elisa CerquiHematology, ASST Spedali Civili, Brescia, Italy.
Francesca FedericoHematology, ASST Spedali Civili, Brescia, Italy.
Chiara PaganiHematology, ASST Spedali Civili, Brescia, Italy.
Silvana ArchettiClinical Chemistry Laboratory, ASST Spedali Civili, Brescia, Italy.
Duilio BrugnoniClinical Chemistry Laboratory, ASST Spedali Civili, Brescia, Italy.
Giuseppe RossiHematology, ASST Spedali Civili, Brescia, Italy.
Alessandra TucciHematology, ASST Spedali Civili, Brescia, Italy.ORCID 0000-0003-3052-7463

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Leukemia, Myeloid, AcuteNeoplasm Recurrence, LocalHumansMutationNuclear ProteinsNucleophosminPrognosisNuclear ProteinsNucleophosmin

Identifiers

PMID38129393
PMCPMC10739830

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.